Lin ZJ - Search Results

1

Immunogenicity and safety of an E. coli-produced bivalent human papillomavirus (type 16 and 18) vaccine: A randomized controlled phase 2 clinical trial.

Wu T, Hu YM, Li J, Chu K, Huang SJ, Zhao H, Wang ZZ, Yang CL, Jiang HM, Wang YJ, Lin ZJ, Pan HR, Sheng W, Wei FX, Li SW, Wang Y, Zhu FC, Li CG, Zhang J, Xia NS. Wu T, et al. Among authors: lin zj. Vaccine. 2015 Jul 31;33(32):3940-6. doi: 10.1016/j.vaccine.2015.06.052. Epub 2015 Jun 19. Vaccine. 2015. PMID: 26100924 Clinical Trial.

2

Robust manufacturing and comprehensive characterization of recombinant hepatitis E virus-like particles in Hecolin(®).

Zhang X, Wei M, Pan H, Lin Z, Wang K, Weng Z, Zhu Y, Xin L, Zhang J, Li S, Xia N, Zhao Q. Zhang X, et al. Vaccine. 2014 Jul 7;32(32):4039-50. doi: 10.1016/j.vaccine.2014.05.064. Epub 2014 Jun 2. Vaccine. 2014. PMID: 24892250

3

Quantitative and epitope-specific antigenicity analysis of the human papillomavirus 6 capsid protein in aqueous solution or when adsorbed on particulate adjuvants.

Li M, Wang X, Cao L, Lin Z, Wei M, Fang M, Li S, Zhang J, Xia N, Zhao Q. Li M, et al. Vaccine. 2016 Aug 17;34(37):4422-8. doi: 10.1016/j.vaccine.2016.07.012. Epub 2016 Jul 15. Vaccine. 2016. PMID: 27426626

4

Real-time stability of a hepatitis E vaccine (Hecolin®) demonstrated with potency assays and multifaceted physicochemical methods.

Zhang X, Wei M, Sun G, Wang X, Li M, Lin Z, Li Z, Li Y, Fang M, Zhang J, Li S, Xia N, Zhao Q. Zhang X, et al. Vaccine. 2016 Nov 21;34(48):5871-5877. doi: 10.1016/j.vaccine.2016.10.045. Epub 2016 Oct 25. Vaccine. 2016. PMID: 27793484

5

Epitope clustering analysis for vaccine-induced human antibodies in relationship to a panel of murine monoclonal antibodies against HPV16 viral capsid.

Zhang C, Huang X, Chen S, Li Y, Li Y, Wang X, Tang J, Xia L, Lin Z, Luo W, Li T, Li S, Zhang J, Xia N, Zhao Q. Zhang C, et al. Vaccine. 2018 Oct 29;36(45):6761-6771. doi: 10.1016/j.vaccine.2018.09.035. Epub 2018 Oct 1. Vaccine. 2018. PMID: 30287156

6

Multifaceted characterization of recombinant protein-based vaccines: An immunochemical toolbox for epitope-specific analyses of the hepatitis E vaccine.

Wang X, Li M, Lin Z, Pan H, Tang Z, Zheng Z, Li S, Zhang J, Xia N, Zhao Q. Wang X, et al. Vaccine. 2018 Nov 29;36(50):7650-7658. doi: 10.1016/j.vaccine.2018.10.089. Epub 2018 Nov 2. Vaccine. 2018. PMID: 30396752

7

Altered antigenicity and immunogenicity of human papillomavirus virus-like particles in the presence of thimerosal.

Chen S, Huang X, Li Y, Wang X, Pan H, Lin Z, Zheng Q, Li S, Zhang J, Xia N, Zhao Q. Chen S, et al. Eur J Pharm Biopharm. 2019 Aug;141:221-231. doi: 10.1016/j.ejpb.2019.05.027. Epub 2019 May 30. Eur J Pharm Biopharm. 2019. PMID: 31154067

8

Comparing immunogenicity of the Escherichia coli-produced bivalent human papillomavirus vaccine in females of different ages.

Chen Q, Zhao H, Yao X, Lin Z, Li J, Lin B, Wang R, Huang Y, Su Y, Wu T, Li C, Pan H, Huang S, Zhang J, Xia N. Chen Q, et al. Vaccine. 2020 Sep 3;38(39):6096-6102. doi: 10.1016/j.vaccine.2020.07.030. Epub 2020 Jul 24. Vaccine. 2020. PMID: 32718817

9

Correlation between ELISA and pseudovirion-based neutralisation assay for detecting antibodies against human papillomavirus acquired by natural infection or by vaccination.

Zhao H, Lin ZJ, Huang SJ, Li J, Liu XH, Guo M, Zhang J, Xia NS, Pan HR, Wu T, Li CG. Zhao H, et al. Among authors: lin zj. Hum Vaccin Immunother. 2014;10(3):740-6. doi: 10.4161/hv.27619. Epub 2014 Jan 2. Hum Vaccin Immunother. 2014. PMID: 24384608 Free PMC article.

10

Efficacy, Safety, and Immunogenicity of an Escherichia coli-Produced Bivalent Human Papillomavirus Vaccine: An Interim Analysis of a Randomized Clinical Trial.

Qiao YL, Wu T, Li RC, Hu YM, Wei LH, Li CG, Chen W, Huang SJ, Zhao FH, Li MQ, Pan QJ, Zhang X, Li Q, Hong Y, Zhao C, Zhang WH, Li YP, Chu K, Li M, Jiang YF, Li J, Zhao H, Lin ZJ, Cui XL, Liu WY, Li CH, Guo DP, Ke LD, Wu X, Tang J, Gao GQ, Li BY, Zhao B, Zheng FX, Dai CH, Guo M, Zhao J, Su YY, Wang JZ, Zhu FC, Li SW, Pan HR, Li YM, Zhang J, Xia NS. Qiao YL, et al. Among authors: lin zj. J Natl Cancer Inst. 2020 Feb 1;112(2):145-153. doi: 10.1093/jnci/djz074. J Natl Cancer Inst. 2020. PMID: 31086947 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

319 results

Search Page